LTC Properties Inc vs uniQure N.V. Ordinary Shares — how do they compare? LTC Properties Inc trades at $42.66 (market cap $2.33B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: LTC Properties Inc is the larger of the two by market cap, and LTC Properties Inc pays a 5.28% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold LTC Properties Inc for 89 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| LTC | QURE | |
|---|---|---|
Market Cap | $2.33B | $1.45B |
Volume | 502,391 | 3,323,243 |
Sector | Real Estate | Health |
52-Week High | $43.50 | $70.59 |
52-Week Low | $34.04 | $9.03 |
Typical Hold Time | 89 Days | 0 Days |
Enterprise Value | $3.07B | $707.46M |
Dividend Yield | 5.28% | — |
Signals from Pluang's Aura AI — not financial advice
LTC Properties (NYSE: LTC) trades at $42.91, down 0.33% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $49.67 implying 16% upside. The REIT reported Q2 2026 EPS of $0.56, beating expectations, and maintains strong profitability with a 38.93% net income margin. Recent news highlights accelerated SHOP portfolio growth with $160 million in acquisitions and consistent monthly dividends of $0.19 per share.
The outlook is positive due to demographic tailwinds in senior housing, but risks include rising interest rates impacting financing costs and execution challenges in portfolio transition. Analyst sentiment is mixed with 32% buy ratings, reflecting balanced risk-reward near current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →